Access keys

Skip to content Accessibility Home News, events and publications Site map Search Privacy policy Help Contact us Terms of use

UK-China Antimicrobial Resistance Initiative

Copyright: M J Richardson
Medical Research Council website
ESRC website
Newton Fund

Call status: Closed
Previous call: 16 December 2015 – 1 March 2016

Summary

The Biotechnology and Biological Sciences Research Council (BBSRC), the Medical Research Council (MRC), the Economic and Social Research Council (ESRC) and the National Natural Science Foundation of China (NSFC) are pleased to invite proposals to the UK-China AMR Partnership Initiative.

This initiative will provide funding for high quality collaborative research projects focussed on addressing the growing global burden of antimicrobial resistance, specifically antibacterial resistance of clinical and veterinary relevance in China.

In total up to £4.5M will be made available for this initiative on the UK side with up to 3M RMB per project from NSFC.

The UK contribution to this call will be channelled from the Newton Fund. This is an initiative intended to strengthen research and innovation partnerships between the UK and emerging knowledge economies to promote economic development and social welfare of partner countries.

The objective of this Newton Fund call will be to deliver significant two to three year research funding for internationally competitive and innovative collaborative projects between researchers from China and the UK that will allow the pursuit of shared research interests. Each project will therefore require both a UK and a Chinese principal investigator.

Scope

Through this call, the funders are looking to support proposals that target one or more of the following areas, with interdisciplinary proposals encouraged:

  • Understanding the development of resistance, the epidemiology, and the transmission dynamics of antibacterial resistance within and between species (genetic, bacterial and host levels)
  • Developing antibiotics, alternative approaches and diagnostics to appropriately treat and prevent resistant bacteria of clinical/veterinary importance. This may include: understanding the mechanisms of action; the use of antibiotics and alternative therapies currently in practise for both humans and animals; development of rapid point of care diagnostics; associated business models and economic issues
  • Understanding behaviours in order to reduce the development, emergence and spread of antibacterial resistance within and beyond human and animal healthcare settings. This would include antibiotic prescribing and real world use, but also broader public health approaches such as in hygiene and infection control practises, in both human and animal settings. It would factor in barriers to behaviour change such as organisational and cultural norms, and financial incentives to prescribe drugs
  • Understanding the functions of different aspects of the healthcare and veterinary systems and sources of health advice as well as their interrelationships. Understanding how 'formal' systems can draw on local, ‘informal’ practices. Is it possible to provide universal access to appropriately regulated therapies? What is the supply chain for antibacterials? Can the supply chain be mapped? What are the global and local incentives for supply and demand of antibacterials?

This call has been launched under the Newton Fund and as such all research projects should be collaborative in nature and be focussed on addressing research of relevance to China.

Timetable

UK-China Antimicrobial Resistance Initiative: Key dates

Call launch Mid December 2015
Intention to submit deadline 15 January 2016
Application deadline 1 March 2016
Panel decision meeting End May 2016
Applicants informed of outcome Early June 2016
Grants commence 1 July 2016

The Newton Fund

The UK contribution will be channelled from the Newton Fund. The Newton Fund is an initiative intended to strengthen research and innovation partnerships between the UK and emerging knowledge economies to promote economic development and social welfare of partner countries. It was launched by the Chancellor in April 2014, and will deliver £375M of funding over the course of five years.

The Fund forms part of the UK’s Official Development Assistance (ODA) commitment which is monitored by the Organisation for Economic Cooperation and Development (OECD). ODA funded activity focuses on outcomes that promote the long-term sustainable growth of countries on the OECD Development Assistance Committee list. Newton Fund countries represent a sub-set of this list.

The Newton Fund requires that the funding be awarded in a manner that fits with Official Development Assistance (ODA) guidelines (PDF). All applications under this call must therefore be compliant with these guidelines.

How to apply

This call is closed to applications.

Further details on this opportunity and information on how to apply can be found on the MRC’s website.

MRC are leading on the UK side of commissioning on behalf of participating Research Councils.


Related calls: collaboration innovation international microbes partnerships Newton Fund